KORU Medical Systems, Inc. Common Stock (DE) (KRMD) — Analysis Summary
KORU Medical Systems, Inc. Common Stock (DE) (KRMD) has a market cap of $175.92M with year-over-year revenue growth of +22.2%. Net margin stands at -6.4%. The stock trades at a P/E ratio of -77.2.
Key Takeaways
- Revenue changed +22.2% year-over-year
- Net margin of -6.4%
- P/E ratio of -77.2
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, KRMD posted revenue growth of +22.2% and trades at a P/E of -77.2.
KORU Medical Systems, Inc. Common Stock (DE) (KRMD)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
73
Headquarters
MAHWAH, NJ
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.